285 related articles for article (PubMed ID: 29027018)
1. Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway.
Laviv Y; Wang JL; Anderson MP; Kasper EM
Neurosurg Rev; 2019 Jun; 42(2):209-226. PubMed ID: 29027018
[TBL] [Abstract][Full Text] [Related]
2. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
4. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
5. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
7. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.
Ponnaluri VK; Vavilala DT; Prakash S; Mukherji M
Biochem Biophys Res Commun; 2013 Aug; 438(1):71-7. PubMed ID: 23872148
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
10. Von hippel-lindau disease: a genetic and clinical review.
Haddad NM; Cavallerano JD; Silva PS
Semin Ophthalmol; 2013; 28(5-6):377-86. PubMed ID: 24138046
[TBL] [Abstract][Full Text] [Related]
11. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.
Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P
J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease.
Frantzen C; Kruizinga RC; van Asselt SJ; Zonnenberg BA; Lenders JW; de Herder WW; Walenkamp AM; Giles RH; Hes FJ; Sluiter WJ; van Pampus MG; Links TP
Neurology; 2012 Aug; 79(8):793-6. PubMed ID: 22875085
[TBL] [Abstract][Full Text] [Related]
14. Study of angiogenic signaling pathways in hemangioblastoma.
Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
Wizigmann-Voos S; Breier G; Risau W; Plate KH
Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
[TBL] [Abstract][Full Text] [Related]
16. Spinal hemangioblastoma presenting with low back pain in pregnancy.
Capone F; Profice P; Pilato F; Zollino M; Colosimo C; Di Lazzaro V
Spine J; 2013 Dec; 13(12):e27-9. PubMed ID: 24051331
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice.
Wang Y; Yang J; Du G; Ma D; Zhou L
Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654
[TBL] [Abstract][Full Text] [Related]
18. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
19. Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling.
Feldman MJ; Sizdahkhani S; Edwards NA; Merrill MJ; Ray-Chaudhury A; Zhuang Z; Lonser RR; Oldfield EH; Chittiboina P
Sci Rep; 2016 Oct; 6():35486. PubMed ID: 27748427
[TBL] [Abstract][Full Text] [Related]
20. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
